Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

68Ga-FAPI PET imaging superior to existing methods for detecting pancreatic cancer

PET imaging with 68Ga-FAPI can more effectively detect and stage pancreatic cancer as compared with 18F-FDG imaging or contrast-enhanced CT, according to new research published in the December issue of The Journal of Nuclear Medicine.

2 Jan 2024

GFH009 disrupts growth signals and triggers apoptosis in hematologic malignancies

A new research paper was published in Oncotarget's Volume 14 on December 20, 2023, entitled, "The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies."

28 Dec 2023

Next-gen sequencing identifies thousands of cancer patients missing out on immunotherapy

Brigham researchers' findings from next-generation sequencing suggest that revising current cancer care guidelines could allow approximately 6,000 more patients in the U.S. to benefit from immunotherapy treatment each year

28 Dec 2023

Degron Therapeutics announced as winner of AFCR's 2023 BRACE Award Venture Competition

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.

27 Dec 2023

Hackensack Meridian's Dr. Mary Sedarous wins ALS United Mid-Atlantic's Flame of Hope Award

Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center's Mary Sedarous, M.D., medical director of the ALS Center, was honored at ALS United Mid-Atlantic's 2023 Annual Celebration with the organization's Flame of Hope Award, recognizing research and innovation.

26 Dec 2023

Spatial profiling predicts recurrence of Hodgkin lymphoma after bone marrow transplant

Cedars-Sinai Cancer investigators have discovered a new way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant.

22 Dec 2023

Groundbreaking treatment tool being developed for male breast cancer diagnosis

Doctors diagnosed Christopher Gregg, Ph.D., member of the Nuclear Control of Cell Growth and Differentiation Program at Huntsman Cancer Institute at the University of Utah (the U) and neuroscientist and professor of neurobiology and human genetics at the U, with stage 4 metastatic breast cancer in 2018.

21 Dec 2023

Brazilian review explores emerging therapies for advanced Hodgkin lymphoma

A new review paper was published in Oncotarget's Volume 14 on December 12, 2023, entitled, "Current perspectives on the management of refractory or relapsed classic Hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability."

20 Dec 2023

IASLC publishes key considerations for managing low-dose CT lung cancer screening programs

Annual low-dose CT screening has been recently shown to result in high cure rates of over 80%, but methods of conducting a lung cancer screening program vary and best practices have yet to emerge.

20 Dec 2023

Endometrial cancer rates rising alarmingly, particularly among Black women

The numbers are stark and deeply troubling. Endometrial cancer - which develops in the lining of the uterus (womb) and is sometimes called uterine cancer - is on the rise in the U.S. In 1987, there were 35,000 cases annually.

19 Dec 2023

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

Amidst a backdrop of industry-wide hurdles like inflation, talent scarcities, and stringent regulatory landscapes, Nona Biosciences is showing great promise as an emerging global leader in biotechnology.

From Nona BioSciences 19 Dec 2023

Scientists identify genetic and epigenetic culprits behind bilateral Wilms tumor

Children with bilateral Wilms tumor have a tumor in each of their kidneys - a condition that strongly suggests an underlying genetic or epigenetic predisposition driving the disease.

18 Dec 2023

Study demonstrates benefits of lung nodule program in expanding access to early diagnosis

Adopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not eligible for lung cancer screening under existing age eligibility criteria, according to a study published in the Journal of Thoracic Oncology, an official journal of the International Association for the Study of Lung Cancer.

18 Dec 2023

Study points to the possibility of using cholesterol-lowering drugs to treat aggressive colorectal tumors

Hard-to-detect colorectal pre-cancerous lesions known as serrated polyps, and the aggressive tumors that develop from them, depend heavily on the ramped-up production of cholesterol, according to a preclinical study from researchers at Weill Cornell Medicine.

18 Dec 2023

Unlocking radiation resistance: Missing protein key to suppressing cancer-fighting cells

A new study finds that radiation therapy (RT) suppresses a key protein called bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) and activates immune suppressive cells.

15 Dec 2023

Physically active women less likely to develop breast cancer before menopause

Regular leisure time physical activity may reduce the risk of breast cancer for women before menopause, according to new research funded by Breast Cancer Now.

15 Dec 2023

QUT scientists discover promising treatment for fatal endometrial cancer

QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15-20 per cent of endometrial cancer patients.

15 Dec 2023

Blueprint Medicines announces approval of AYVAKYT for treatment of ISM patients in Europe

Blueprint Medicines Corporation today announced the European Commission has approved AYVAKYT® (avapritinib) for the treatment of adult patients with indolent systemic mastocytosis (ISM) with moderate to severe symptoms inadequately controlled on symptomatic treatment. AYVAKYT is the first and only approved therapy for people living with ISM in Europe.

15 Dec 2023

Internationally renowned breast medical oncologist joins the David Geffen School of Medicine at UCLA

Dr. Aditya Bardia, a renowned breast medical oncologist and physician scientist who specializes in developing novel targeted and personalized therapies, has joined the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center where he will assume several leadership roles across the institution.

14 Dec 2023

New advance in the development of a test for early diagnosis of cancer

Blood cells reveal tumors in the body. Researchers at the Paul Scherrer Institute achieve an advance with the development of a test for early diagnosis of cancer.

14 Dec 2023

Oncology News and Research

Further Reading

68Ga-FAPI PET imaging superior to existing methods for detecting pancreatic cancer

GFH009 disrupts growth signals and triggers apoptosis in hematologic malignancies

Next-gen sequencing identifies thousands of cancer patients missing out on immunotherapy

Degron Therapeutics announced as winner of AFCR's 2023 BRACE Award Venture Competition

Hackensack Meridian's Dr. Mary Sedarous wins ALS United Mid-Atlantic's Flame of Hope Award

Spatial profiling predicts recurrence of Hodgkin lymphoma after bone marrow transplant

Groundbreaking treatment tool being developed for male breast cancer diagnosis

Brazilian review explores emerging therapies for advanced Hodgkin lymphoma

IASLC publishes key considerations for managing low-dose CT lung cancer screening programs

Endometrial cancer rates rising alarmingly, particularly among Black women

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

Scientists identify genetic and epigenetic culprits behind bilateral Wilms tumor

Study demonstrates benefits of lung nodule program in expanding access to early diagnosis

Study points to the possibility of using cholesterol-lowering drugs to treat aggressive colorectal tumors

Unlocking radiation resistance: Missing protein key to suppressing cancer-fighting cells

Physically active women less likely to develop breast cancer before menopause

QUT scientists discover promising treatment for fatal endometrial cancer

Blueprint Medicines announces approval of AYVAKYT for treatment of ISM patients in Europe

Internationally renowned breast medical oncologist joins the David Geffen School of Medicine at UCLA

New advance in the development of a test for early diagnosis of cancer

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News